CDKN3 and cancer: The observed inhibition of cancer cell proliferation by minocycline can be connected with downregulation of cell-cycle regulatory proteins, such as cyclin D, cyclin E and cyclin-dependent kinases 1, 2 and 4, as well as with upregulation of a cyclin-dependent kinase inhibitor—protein p27 [39,48].